Clinic
Guthrie Medical Group, P.C.
Guthrie Medical Group, P.C. was paid $82.19M by Medicaid between Jan 2018 and Dec 2024, across 414 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoGUTHRIE MEDICAL GROUP, P.C.
SAYRE, PA 18840
SAYRE, PA 18840
33aNPI1245246644assigned 07/31/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$82.19M
24GClaims1,899,181
24DCodes billed414
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Pennsylvania
Rank by total paid#1 of 14
Median peer was paid$98K
This provider vs. median843×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SCOPELLITI, JOSEPH controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 111,699 | $4.05M | |
| 2019 | 151,752 | $5.39M | |
| 2020 | 186,280 | $6.67M | |
| 2021 | 369,564 | $16.60M | |
| 2022 | 385,300 | $18.84M | |
| 2023 | 403,232 | $18.15M | |
| 2024incomplete | 291,354 | $12.50M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 274,083 | 260,775 | $27.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 282,590 | 266,078 | $19.53M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 24,484 | 22,749 | $2.04M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 21,128 | 20,967 | $1.94M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 12,366 | 12,309 | $1.81M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 20,007 | 19,190 | $1.67M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.0% | 11,862 | 11,535 | $1.67M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 16,404 | 16,345 | $1.54M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 13,474 | 13,424 | $1.30M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.5% | 3,805 | 3,728 | $1.24M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 16,057 | 15,686 | $1.11M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 13,232 | 13,084 | $1.09M |
402 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 8,491 | $882K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 29,371 | $656K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 53,554 | $630K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 35,525 | $615K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 4,333 | $612K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 10,368 | $602K |
| 80053 | Comprehensive metabolic panel | <1% | 54,835 | $585K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16,852 | $529K |
| 80061 | Lipid panel | <1% | 29,656 | $398K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21,227 | $365K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 4,485 | $365K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 15,900 | $346K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 9,818 | $324K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 9,806 | $324K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,888 | $313K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 8,825 | $287K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,644 | $283K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 20,182 | $273K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 2,990 | $266K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 6,489 | $247K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18,578 | $237K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 25,786 | $232K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29,644 | $225K |
| 96127 | <1% | 45,909 | $222K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,205 | $217K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,644 | $188K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 9,162 | $185K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,686 | $181K |
| 87631 | <1% | 1,395 | $180K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,683 | $169K |
| 0352U | <1% | 1,691 | $168K | |
| 82607 | <1% | 11,361 | $163K | |
| 80050 | General health panel | <1% | 2,595 | $162K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,154 | $158K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,954 | $149K |
| 71045 | Radiologic examination, chest; single view | <1% | 18,687 | $148K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 3,183 | $147K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,018 | $144K |
| 76830 | Ultrasound, transvaginal | <1% | 2,654 | $142K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,040 | $141K |
| 92551 | <1% | 13,242 | $141K | |
| 20610 | <1% | 2,995 | $138K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16,555 | $136K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,624 | $133K |
| 87660 | <1% | 6,199 | $131K | |
| 84439 | <1% | 14,953 | $131K | |
| 82746 | <1% | 9,394 | $130K | |
| 87081 | <1% | 19,590 | $129K | |
| 93000 | <1% | 8,324 | $129K | |
| V2020 | Frames, purchases | <1% | 10,846 | $128K |
| 90686 | <1% | 19,372 | $128K | |
| 85027 | <1% | 18,857 | $126K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,508 | $126K |
| 87480 | <1% | 5,789 | $124K | |
| 73564 | <1% | 4,034 | $123K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,851 | $118K |
| 92134 | <1% | 3,331 | $116K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,179 | $116K |
| 83970 | <1% | 2,602 | $107K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,369 | $106K |
| 82728 | <1% | 7,361 | $96K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,077 | $94K |
| 87510 | <1% | 4,909 | $93K | |
| 95886 | <1% | 1,005 | $90K | |
| 87507 | <1% | 236 | $87K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,436 | $86K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,754 | $81K |
| 73610 | <1% | 4,243 | $81K | |
| 73630 | <1% | 4,355 | $81K | |
| 99205 | Prolong outpt/office vis | <1% | 431 | $78K |
| 76642 | <1% | 1,960 | $75K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,528 | $75K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,394 | $74K |
| 76536 | <1% | 1,309 | $67K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,109 | $66K |
| 93971 | <1% | 882 | $65K | |
| 73110 | <1% | 2,946 | $64K | |
| 92567 | <1% | 4,670 | $64K | |
| 92557 | <1% | 1,995 | $63K | |
| 73030 | <1% | 2,967 | $62K | |
| 86803 | <1% | 3,837 | $61K | |
| 0001A | <1% | 1,457 | $58K | |
| 0002A | <1% | 1,361 | $58K | |
| 73221 | <1% | 650 | $58K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 347 | $54K |
| 72110 | <1% | 1,663 | $52K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,315 | $49K |
| 92002 | <1% | 1,242 | $49K | |
| 83721 | <1% | 4,717 | $48K | |
| 73130 | <1% | 2,373 | $48K | |
| 83540 | <1% | 6,934 | $47K | |
| 83550 | <1% | 5,860 | $46K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 537 | $44K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,763 | $44K |
| 86762 | <1% | 2,728 | $43K | |
| 87186 | <1% | 4,926 | $43K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 181 | $43K |
| 88307 | <1% | 541 | $42K | |
| 90474 | <1% | 3,651 | $42K | |
| 83880 | <1% | 1,087 | $41K | |
| 82043 | <1% | 6,271 | $41K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 776 | $40K |
| 82570 | <1% | 6,832 | $40K | |
| 76801 | <1% | 540 | $40K | |
| 90715 | <1% | 3,001 | $40K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 918 | $39K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 392 | $38K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 746 | $38K |
| 94060 | <1% | 1,275 | $36K | |
| 93975 | <1% | 435 | $35K | |
| 84481 | <1% | 1,843 | $35K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 775 | $35K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 368 | $34K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 299 | $34K |
| 93923 | <1% | 377 | $33K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,772 | $33K |
| 84480 | <1% | 2,497 | $32K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 71 | $32K |
| 97597 | <1% | 913 | $32K | |
| 73502 | <1% | 1,253 | $31K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 869 | $30K |
| 94729 | <1% | 919 | $29K | |
| 71271 | <1% | 493 | $29K | |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | <1% | 990 | $29K |
| 99460 | <1% | 485 | $28K | |
| 83001 | <1% | 1,513 | $28K | |
| 87340 | <1% | 2,386 | $27K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 703 | $26K |
| 81003 | <1% | 10,728 | $26K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 1,521 | $25K |
| 88304 | <1% | 1,618 | $25K | |
| 0012A | <1% | 635 | $25K | |
| 84146 | <1% | 1,167 | $25K | |
| 86140 | <1% | 5,226 | $25K | |
| 88342 | <1% | 600 | $24K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 1,183 | $24K |
| 86703 | <1% | 1,770 | $24K | |
| 85651 | <1% | 6,085 | $24K | |
| 83525 | <1% | 2,085 | $24K | |
| 83735 | <1% | 3,266 | $22K | |
| 90670 | <1% | 11,124 | $22K | |
| 64615 | <1% | 167 | $22K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 414 | $22K |
| 84702 | <1% | 1,371 | $22K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,655 | $22K |
| 86850 | <1% | 2,176 | $21K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 76,246 | $21K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 347 | $20K |
| 87506 | <1% | 88 | $20K | |
| 98940 | <1% | 1,908 | $19K | |
| 73562 | <1% | 694 | $19K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 877 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,133 | $19K |
| 85610 | <1% | 4,530 | $18K | |
| 80074 | <1% | 330 | $17K | |
| 83655 | <1% | 1,522 | $17K | |
| 00142 | <1% | 215 | $17K | |
| 86618 | <1% | 966 | $17K | |
| 0011A | <1% | 505 | $17K | |
| 84134 | <1% | 1,088 | $17K | |
| 83002 | <1% | 934 | $17K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 327 | $16K |
| 84153 | <1% | 816 | $16K | |
| 84403 | <1% | 613 | $16K | |
| 93970 | <1% | 178 | $16K | |
| 95117 | <1% | 1,410 | $15K | |
| 77065 | Tomosynthesis, mammo | <1% | 343 | $15K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,056 | $15K |
| 87070 | <1% | 1,652 | $14K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 108 | $14K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,092 | $13K |
| 90656 | <1% | 1,359 | $13K | |
| 74018 | <1% | 828 | $13K | |
| 82784 | <1% | 451 | $13K | |
| 86431 | <1% | 2,063 | $13K | |
| 83690 | <1% | 1,958 | $13K | |
| 90698 | <1% | 7,579 | $13K | |
| 84703 | <1% | 1,564 | $13K | |
| 0071A | <1% | 319 | $13K | |
| 93296 | <1% | 782 | $13K | |
| 94727 | <1% | 390 | $13K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 125 | $13K |
| 99152 | <1% | 801 | $12K | |
| 85018 | <1% | 3,852 | $12K | |
| 82670 | <1% | 481 | $12K | |
| 96158 | <1% | 209 | $12K | |
| 00731 | <1% | 98 | $12K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,328 | $11K |
| 0072A | <1% | 273 | $11K | |
| 90680 | <1% | 7,170 | $11K | |
| 88112 | <1% | 186 | $11K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 21,923 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 121 | $10K |
| 0004A | <1% | 247 | $10K | |
| 93298 | <1% | 271 | $10K | |
| 90651 | <1% | 1,750 | $10K | |
| 72050 | <1% | 265 | $9K | |
| 97161 | <1% | 117 | $9K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 80 | $9K |
| 82950 | <1% | 1,376 | $9K | |
| 80076 | <1% | 983 | $9K | |
| 81001 | <1% | 2,766 | $9K | |
| 90633 | <1% | 4,835 | $8K | |
| 71250 | <1% | 162 | $8K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 39 | $8K |
| 86900 | <1% | 2,229 | $8K | |
| 86901 | <1% | 2,209 | $8K | |
| 95816 | <1% | 245 | $8K | |
| 87205 | <1% | 1,680 | $8K | |
| 81025 | <1% | 1,116 | $8K | |
| 86706 | <1% | 656 | $8K | |
| 90744 | <1% | 3,109 | $7K | |
| 74183 | <1% | 60 | $7K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 25 | $7K |
| 90838 | <1% | 62 | $7K | |
| 88341 | <1% | 51 | $7K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 64 | $7K |
| 77080 | <1% | 487 | $7K | |
| 73140 | <1% | 340 | $7K | |
| 69210 | <1% | 215 | $7K | |
| 90732 | <1% | 69 | $7K | |
| 84144 | <1% | 349 | $7K | |
| 76770 | <1% | 127 | $6K | |
| 95913 | <1% | 25 | $6K | |
| 94726 | <1% | 307 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 93 | $6K |
| 84550 | <1% | 1,141 | $6K | |
| 96156 | <1% | 75 | $6K | |
| 82550 | <1% | 856 | $6K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 31 | $6K |
| 80069 | <1% | 628 | $6K | |
| S0620 | Routine ophthalmological examination including refraction; new patient | <1% | 142 | $6K |
| 73080 | <1% | 294 | $6K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 53 | $5K |
| 87077 | <1% | 648 | $5K | |
| 90734 | <1% | 3,034 | $5K | |
| 3074F | <1% | 9,040 | $5K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 49 | $5K |
| 0031A | <1% | 112 | $5K | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 165 | $5K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 68 | $5K |
| 77066 | Tomosynthesis, mammo | <1% | 85 | $5K |
| 82150 | <1% | 712 | $5K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 56 | $4K |
| 92015 | Determination of refractive state | <1% | 1,715 | $4K |
| 80055 | <1% | 103 | $4K | |
| 82248 | <1% | 703 | $4K | |
| 31575 | <1% | 43 | $4K | |
| 00126 | <1% | 38 | $4K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 633 | $4K |
| 86308 | <1% | 622 | $4K | |
| 90707 | <1% | 791 | $4K | |
| 3078F | <1% | 7,198 | $4K | |
| 99459 | <1% | 180 | $4K | |
| 93294 | <1% | 254 | $4K | |
| 59025 | Fetal non-stress test | <1% | 114 | $4K |
| 90716 | <1% | 863 | $4K | |
| 11102 | <1% | 53 | $4K | |
| 81002 | <1% | 1,168 | $4K | |
| 0064A | <1% | 81 | $3K | |
| 90710 | <1% | 1,292 | $3K | |
| 90677 | <1% | 242 | $3K | |
| 87427 | <1% | 272 | $3K | |
| 82274 | <1% | 292 | $3K | |
| 76981 | <1% | 140 | $3K | |
| 90473 | <1% | 268 | $3K | |
| 00811 | <1% | 28 | $3K | |
| 78264 | <1% | 83 | $3K | |
| 99385 | <1% | 24 | $3K | |
| 87329 | <1% | 232 | $3K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 15 | $3K |
| 87147 | <1% | 595 | $3K | |
| 90750 | <1% | 25 | $3K | |
| 90696 | <1% | 1,108 | $3K | |
| 87046 | <1% | 271 | $3K | |
| 87045 | <1% | 271 | $3K | |
| 51798 | <1% | 206 | $2K | |
| 87328 | <1% | 195 | $2K | |
| 97803 | <1% | 282 | $2K | |
| 73590 | <1% | 158 | $2K | |
| 95251 | <1% | 65 | $2K | |
| 95910 | <1% | 25 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $2K |
| 31231 | <1% | 13 | $2K | |
| 90688 | <1% | 164 | $2K | |
| 93295 | <1% | 71 | $2K | |
| 95909 | <1% | 26 | $2K | |
| 3079F | <1% | 2,125 | $2K | |
| 86376 | <1% | 153 | $2K | |
| 86160 | <1% | 147 | $2K | |
| 99490 | Ccm add 20min | <1% | 384 | $2K |
| 90785 | <1% | 150 | $2K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 27 | $2K |
| 99462 | <1% | 67 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 89 | $2K |
| 82533 | <1% | 115 | $2K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 70 | $2K |
| 0124A | <1% | 42 | $2K | |
| 92552 | <1% | 91 | $2K | |
| 84156 | <1% | 430 | $2K | |
| 73523 | <1% | 43 | $2K | |
| 84100 | <1% | 284 | $2K | |
| 96160 | <1% | 484 | $2K | |
| 83615 | <1% | 236 | $2K | |
| 82105 | <1% | 93 | $2K | |
| 00813 | <1% | 13 | $2K | |
| 90648 | <1% | 3,560 | $1K | |
| 87075 | <1% | 136 | $1K | |
| 76870 | <1% | 38 | $1K | |
| 43237 | <1% | 12 | $1K | |
| 73560 | <1% | 73 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 44 | $1K |
| 0054A | <1% | 29 | $1K | |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 33 | $1K |
| 43235 | <1% | 12 | $1K | |
| 96152 | <1% | 31 | $1K | |
| 92556 | <1% | 51 | $1K | |
| 92136 | <1% | 39 | $1K | |
| 93016 | <1% | 68 | $1K | |
| 85652 | <1% | 422 | $1K | |
| 87493 | <1% | 24 | $1K | |
| 97162 | <1% | 12 | $997.34 | |
| 93225 | <1% | 61 | $977.10 | |
| 70498 | <1% | 12 | $972.87 | |
| 92083 | <1% | 24 | $966.92 | |
| 93018 | <1% | 81 | $892.57 | |
| 86704 | <1% | 90 | $866.70 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 26 | $851.68 |
| 86800 | <1% | 46 | $758.22 | |
| 58300 | <1% | 12 | $749.97 | |
| 70486 | <1% | 13 | $748.75 | |
| 85705 | <1% | 79 | $723.69 | |
| 98928 | <1% | 13 | $709.05 | |
| 81015 | <1% | 237 | $685.63 | |
| 90723 | <1% | 2,248 | $674.50 | |
| 92558 | <1% | 232 | $671.60 | |
| 85045 | <1% | 163 | $661.73 | |
| 3075F | <1% | 703 | $615.00 | |
| 93280 | <1% | 13 | $598.03 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 681 | $552.50 |
| 86592 | <1% | 166 | $545.91 | |
| 92250 | <1% | 12 | $538.90 | |
| 83718 | <1% | 75 | $536.83 | |
| 97802 | <1% | 14 | $531.76 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 32 | $510.24 |
| 78227 | <1% | 12 | $506.42 | |
| 95800 | <1% | 13 | $492.57 | |
| 90671 | <1% | 36 | $491.91 | |
| 85014 | <1% | 178 | $490.56 | |
| 86769 | <1% | 12 | $455.04 | |
| 20550 | <1% | 13 | $454.30 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 28 | $441.00 |
| 99310 | Prolong nursin fac eval 15m | <1% | 51 | $431.82 |
| 77062 | <1% | 13 | $424.32 | |
| 93226 | <1% | 12 | $399.00 | |
| 11721 | <1% | 12 | $343.05 | |
| 90697 | <1% | 26 | $340.00 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 14 | $320.15 |
| 92133 | <1% | 15 | $314.88 | |
| 93227 | <1% | 24 | $311.22 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 106 | $309.76 |
| 85378 | <1% | 28 | $291.71 | |
| 94010 | <1% | 39 | $288.79 | |
| 90620 | <1% | 28 | $247.42 | |
| 73000 | <1% | 13 | $243.99 | |
| 85730 | <1% | 38 | $235.75 | |
| 90700 | <1% | 264 | $218.50 | |
| 80164 | <1% | 13 | $214.79 | |
| 85007 | <1% | 57 | $213.54 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $200.22 |
| 73090 | <1% | 14 | $187.70 | |
| 88720 | <1% | 25 | $182.09 | |
| 90672 | <1% | 397 | $169.66 | |
| 82951 | <1% | 12 | $168.25 | |
| 99318 | <1% | 25 | $168.08 | |
| 82565 | <1% | 26 | $157.07 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $146.94 |
| 88302 | <1% | 13 | $133.15 | |
| 88311 | <1% | 12 | $118.92 | |
| 94760 | <1% | 870 | $91.95 | |
| 90685 | <1% | 248 | $86.63 | |
| 93325 | <1% | 13 | $78.84 | |
| 84460 | <1% | 14 | $75.36 | |
| 3044F | <1% | 598 | $70.00 | |
| 82947 | <1% | 14 | $69.34 | |
| 84450 | <1% | 14 | $69.14 | |
| 99484 | <1% | 82 | $68.19 | |
| 82952 | <1% | 12 | $47.47 | |
| 96161 | <1% | 14 | $36.92 | |
| 91301 | <1% | 1,102 | $26.46 | |
| 91300 | 0% | 3,483 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 320 | $0.00 |
| 3051F | 0% | 28 | $0.00 | |
| 91322 | 0% | 13 | $0.00 | |
| 2022F | 0% | 16 | $0.00 | |
| 3046F | 0% | 21 | $0.00 | |
| 91307 | 0% | 682 | $0.00 | |
| 91306 | 0% | 70 | $0.00 | |
| 91303 | 0% | 108 | $0.00 | |
| 91305 | 0% | 150 | $0.00 | |
| 2023F | 0% | 12 | $0.00 | |
| J0178 | Injection, aflibercept, 1 mg | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCOPELLITI, JOSEPH (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Guthrie Medical Group PC | Sayre, PA | $2.94M |
| Vna Health System | Shamokin, PA | $192K |
| Gutharie Medical Group, P.C. | Sayre, PA | $156K |
| Guthrie Medical Group, P.C. | Corning, NY | $77K |
| Guthrie Medical Group, P.C. | Sayre, PA | $41K |
| Guthrie Medical Group, P.C. | Sayre, PA | $17K |
| Guthrie Medical Group, P.C. | Dushore, PA | $13K |
| Guthrie Medical Group, P.C. | Wellsboro, PA | $10K |
| Guthrie Medical Group, P.C. | Sayre, PA | $6K |
| Guthrie Medical Group, P.C. | Troy, PA | $5K |
| Guthrie Medical Group, P.C. | Sayre, PA | $3K |
| Guthrie Medical Group, P.C. | Sayre, PA | $3K |
| Guthrie Medical Group, P.C. | Towanda, PA | $2K |
| Guthrie Medical Group, P.C. | Sayre, PA | $1K |
| Guthrie Medical Group PC | Sayre, PA | $178.70 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.